vs

Side-by-side financial comparison of WillScot Holdings Corp (WSC) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $566.0M, roughly 1.7× WillScot Holdings Corp). DENTSPLY SIRONA Inc. runs the higher net margin — -15.2% vs -33.1%, a 17.9% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -6.1%). WillScot Holdings Corp produced more free cash flow last quarter ($149.7M vs $60.0M). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -1.8%).

WillScot Holdings Corp is a leading provider of modular space solutions and portable storage services across North America. It serves a wide range of sectors including construction, commercial development, education, healthcare, government projects, and special events, offering flexible, scalable temporary and semi-permanent space solutions tailored to diverse client needs.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

WSC vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.7× larger
XRAY
$961.0M
$566.0M
WSC
Growing faster (revenue YoY)
XRAY
XRAY
+12.3% gap
XRAY
6.2%
-6.1%
WSC
Higher net margin
XRAY
XRAY
17.9% more per $
XRAY
-15.2%
-33.1%
WSC
More free cash flow
WSC
WSC
$89.7M more FCF
WSC
$149.7M
$60.0M
XRAY
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-1.8%
WSC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
WSC
WSC
XRAY
XRAY
Revenue
$566.0M
$961.0M
Net Profit
$-187.3M
$-146.0M
Gross Margin
50.4%
46.1%
Operating Margin
-32.5%
-14.5%
Net Margin
-33.1%
-15.2%
Revenue YoY
-6.1%
6.2%
Net Profit YoY
-310.0%
66.0%
EPS (diluted)
$-1.02
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
WSC
WSC
XRAY
XRAY
Q4 25
$566.0M
$961.0M
Q3 25
$566.8M
$904.0M
Q2 25
$589.1M
$936.0M
Q1 25
$559.6M
$879.0M
Q4 24
$602.5M
$905.0M
Q3 24
$601.4M
$951.0M
Q2 24
$604.6M
$984.0M
Q1 24
$587.2M
$953.0M
Net Profit
WSC
WSC
XRAY
XRAY
Q4 25
$-187.3M
$-146.0M
Q3 25
$43.3M
$-427.0M
Q2 25
$47.9M
$-45.0M
Q1 25
$43.1M
$20.0M
Q4 24
$89.2M
$-430.0M
Q3 24
$-70.5M
$-494.0M
Q2 24
$-46.9M
$-4.0M
Q1 24
$56.2M
$18.0M
Gross Margin
WSC
WSC
XRAY
XRAY
Q4 25
50.4%
46.1%
Q3 25
49.7%
48.8%
Q2 25
50.3%
52.4%
Q1 25
53.7%
53.0%
Q4 24
55.8%
49.3%
Q3 24
53.5%
52.1%
Q2 24
54.1%
51.9%
Q1 24
54.0%
53.1%
Operating Margin
WSC
WSC
XRAY
XRAY
Q4 25
-32.5%
-14.5%
Q3 25
21.0%
-24.1%
Q2 25
21.5%
-13.7%
Q1 25
21.3%
7.2%
Q4 24
28.9%
-56.2%
Q3 24
-5.9%
-48.6%
Q2 24
-0.9%
5.1%
Q1 24
22.1%
4.4%
Net Margin
WSC
WSC
XRAY
XRAY
Q4 25
-33.1%
-15.2%
Q3 25
7.6%
-47.2%
Q2 25
8.1%
-4.8%
Q1 25
7.7%
2.3%
Q4 24
14.8%
-47.5%
Q3 24
-11.7%
-51.9%
Q2 24
-7.7%
-0.4%
Q1 24
9.6%
1.9%
EPS (diluted)
WSC
WSC
XRAY
XRAY
Q4 25
$-1.02
$-0.74
Q3 25
$0.24
$-2.14
Q2 25
$0.26
$-0.22
Q1 25
$0.23
$0.10
Q4 24
$0.48
$-2.09
Q3 24
$-0.37
$-2.46
Q2 24
$-0.25
$-0.02
Q1 24
$0.29
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
WSC
WSC
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$14.6M
$326.0M
Total DebtLower is stronger
$3.6B
$2.3B
Stockholders' EquityBook value
$856.3M
$1.3B
Total Assets
$5.8B
$5.4B
Debt / EquityLower = less leverage
4.15×
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
WSC
WSC
XRAY
XRAY
Q4 25
$14.6M
$326.0M
Q3 25
$14.8M
$363.0M
Q2 25
$12.8M
$359.0M
Q1 25
$10.7M
$398.0M
Q4 24
$9.0M
$272.0M
Q3 24
$11.0M
$296.0M
Q2 24
$5.9M
$279.0M
Q1 24
$13.1M
$291.0M
Total Debt
WSC
WSC
XRAY
XRAY
Q4 25
$3.6B
$2.3B
Q3 25
$3.6B
Q2 25
$3.7B
Q1 25
$3.6B
Q4 24
$3.7B
$1.7B
Q3 24
$3.6B
Q2 24
$3.5B
Q1 24
$3.5B
Stockholders' Equity
WSC
WSC
XRAY
XRAY
Q4 25
$856.3M
$1.3B
Q3 25
$1.1B
$1.5B
Q2 25
$1.0B
$2.0B
Q1 25
$1.0B
$2.0B
Q4 24
$1.0B
$1.9B
Q3 24
$1.1B
$2.5B
Q2 24
$1.2B
$3.1B
Q1 24
$1.3B
$3.3B
Total Assets
WSC
WSC
XRAY
XRAY
Q4 25
$5.8B
$5.4B
Q3 25
$6.1B
$5.7B
Q2 25
$6.1B
$6.1B
Q1 25
$6.0B
$6.0B
Q4 24
$6.0B
$5.8B
Q3 24
$6.0B
$6.6B
Q2 24
$6.0B
$6.9B
Q1 24
$6.2B
$7.1B
Debt / Equity
WSC
WSC
XRAY
XRAY
Q4 25
4.15×
1.70×
Q3 25
3.39×
Q2 25
3.55×
Q1 25
3.56×
Q4 24
3.62×
0.90×
Q3 24
3.42×
Q2 24
2.88×
Q1 24
2.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
WSC
WSC
XRAY
XRAY
Operating Cash FlowLast quarter
$158.9M
$101.0M
Free Cash FlowOCF − Capex
$149.7M
$60.0M
FCF MarginFCF / Revenue
26.5%
6.2%
Capex IntensityCapex / Revenue
1.6%
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$737.7M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
WSC
WSC
XRAY
XRAY
Q4 25
$158.9M
$101.0M
Q3 25
$191.2M
$79.0M
Q2 25
$205.3M
$48.0M
Q1 25
$206.6M
$7.0M
Q4 24
$178.9M
$87.0M
Q3 24
$-1.6M
$141.0M
Q2 24
$175.6M
$208.0M
Q1 24
$208.7M
$25.0M
Free Cash Flow
WSC
WSC
XRAY
XRAY
Q4 25
$149.7M
$60.0M
Q3 25
$186.9M
$40.0M
Q2 25
$199.0M
$16.0M
Q1 25
$202.0M
$-12.0M
Q4 24
$176.6M
$36.0M
Q3 24
$-4.9M
$98.0M
Q2 24
$169.4M
$156.0M
Q1 24
$202.1M
$-9.0M
FCF Margin
WSC
WSC
XRAY
XRAY
Q4 25
26.5%
6.2%
Q3 25
33.0%
4.4%
Q2 25
33.8%
1.7%
Q1 25
36.1%
-1.4%
Q4 24
29.3%
4.0%
Q3 24
-0.8%
10.3%
Q2 24
28.0%
15.9%
Q1 24
34.4%
-0.9%
Capex Intensity
WSC
WSC
XRAY
XRAY
Q4 25
1.6%
4.3%
Q3 25
0.7%
4.3%
Q2 25
1.1%
3.4%
Q1 25
0.8%
2.2%
Q4 24
0.4%
5.6%
Q3 24
0.6%
4.5%
Q2 24
1.0%
5.3%
Q1 24
1.1%
3.6%
Cash Conversion
WSC
WSC
XRAY
XRAY
Q4 25
Q3 25
4.41×
Q2 25
4.28×
Q1 25
4.80×
0.35×
Q4 24
2.01×
Q3 24
Q2 24
Q1 24
3.71×
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

WSC
WSC

Modular Space Leasing$249.8M44%
Value Added Product And Services$101.0M18%
Portable Storage Leasing$83.0M15%
Delivery Revenue$48.2M9%
Installation Revenue$45.0M8%
Rental Units$19.7M3%
New Units$15.5M3%
Value Added Services$10.3M2%
Other Leasing Related Products And Services$3.8M1%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons